Bank Of America Corp Novan, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.05 - $2.04 $58 - $114	-56 Reduced 98.25%	1 $0
Q4 2022 Feb 10, 2023	BUY	$0.82 - $1.48 $45 - $82	56 Added 5600.0%	57 $0
Q3 2022 Nov 14, 2022	BUY	$1.76 - $3.03 $1 - $3	1 New	1 $0
Q1 2022 May 16, 2022	SELL	$2.95 - $4.41 $295 - $441	-100 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$4.03 - $8.15 $403 - $815	100 New	100 $0

Q3 2021 Nov 15, 2021	SELL	$7.48 - $10.17 $688 - $935	-92 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$7.8 - $17.35 $717 - $1,596	92 New	92 $1,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.